In the article titled "HDR Brachytherapy in the Management of High-Risk Prostate Cancer" \[[@B1]\], there was an error in Table 2, which should be corrected as follows: For Hoskin et al. \[32\], the dose should read 35.75 Gy in 13 fractions EBRT, not 55 Gy in 20 fractions EBRT.

###### 

Estimated equivalent doses (2 Gy per fraction) for published HDR schedules using the EQD2 formula, assuming *α*/*β* for prostate cancer of 1.5 Gy \[19\].

  Author                   Schedule                                                               EQD2 prostate (*α*/*β* 1.5 Gy)
  ------------------------ ---------------------------------------------------------------------- --------------------------------
  Galalae et al. \[36\]    50 Gy WPRT, 40 Gy Prostate EBRT, 2 fractions HDR (9 Gy per fraction)   94 Gy
  Åström et al. \[30\]     50 Gy in 25 fractions EBRT, 2 fractions HDR (10 Gy per fraction)       115.7 Gy
  Martinez et al. \[28\]   46 Gy in 23 fractions EBRT, 2 fractions HDR (11.5 Gy per fraction)     131.4 Gy
  Hoskin et al. \[32\]     35.75 Gy in 13 fractions EBRT, 2 fractions HDR (8.5 Gy per fraction)   92.0 Gy
